These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27110445)

  • 1. Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice - comparison of 1.5 and 3 Tesla magnetic resonance imaging.
    Lysandropoulos AP; Absil J; Metens T; Mavroudakis N; Guisset F; Van Vlierberghe E; Smeets D; David P; Maertens A; Van Hecke W
    Brain Behav; 2016 Feb; 6(2):e00422. PubMed ID: 27110445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy.
    Steenwijk MD; Amiri H; Schoonheim MM; de Sitter A; Barkhof F; Pouwels PJW; Vrenken H
    Neuroimage Clin; 2017; 15():843-853. PubMed ID: 28794970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.
    Storelli L; Rocca MA; Pagani E; Van Hecke W; Horsfield MA; De Stefano N; Rovira A; Sastre-Garriga J; Palace J; Sima D; Smeets D; Filippi M;
    Radiology; 2018 Aug; 288(2):554-564. PubMed ID: 29714673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
    Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
    J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS.
    Zivadinov R; Bergsland N; Korn JR; Dwyer MG; Khan N; Medin J; Price JC; Weinstock-Guttman B; Silva D;
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):289-295. PubMed ID: 29170269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
    Biberacher V; Schmidt P; Keshavan A; Boucard CC; Righart R; Sämann P; Preibisch C; Fröbel D; Aly L; Hemmer B; Zimmer C; Henry RG; Mühlau M
    Neuroimage; 2016 Nov; 142():188-197. PubMed ID: 27431758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis.
    Goodkin O; Prados F; Vos SB; Pemberton H; Collorone S; Hagens MHJ; Cardoso MJ; Yousry TA; Thornton JS; Sudre CH; Barkhof F;
    Neuroimage Clin; 2021; 29():102542. PubMed ID: 33418171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis.
    Dwyer MG; Silva D; Bergsland N; Horakova D; Ramasamy D; Durfee J; Vaneckova M; Havrdova E; Zivadinov R
    Neuroimage Clin; 2017; 15():769-779. PubMed ID: 28706852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intercontinental validation of brain volume measurements using MSmetrix.
    Finkelsztejn A; Fragoso YD; Bastos EA; Duarte JA; Varela JS; Houbrechts R; Sima D; Van Hecke W
    Neuroradiol J; 2018 Apr; 31(2):147-149. PubMed ID: 28730868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis.
    Guo C; Ferreira D; Fink K; Westman E; Granberg T
    Eur Radiol; 2019 Mar; 29(3):1355-1364. PubMed ID: 30242503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
    Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
    PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images.
    Jain S; Sima DM; Ribbens A; Cambron M; Maertens A; Van Hecke W; De Mey J; Barkhof F; Steenwijk MD; Daams M; Maes F; Van Huffel S; Vrenken H; Smeets D
    Neuroimage Clin; 2015; 8():367-75. PubMed ID: 26106562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI.
    Meier DS; Guttmann CRG; Tummala S; Moscufo N; Cavallari M; Tauhid S; Bakshi R; Weiner HL
    J Neuroimaging; 2018 Jan; 28(1):36-47. PubMed ID: 29235194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
    Chu R; Hurwitz S; Tauhid S; Bakshi R
    BMC Neurol; 2017 Sep; 17(1):172. PubMed ID: 28874119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain volume loss in individuals over time: Source of variance and limits of detectability.
    Narayanan S; Nakamura K; Fonov VS; Maranzano J; Caramanos Z; Giacomini PS; Collins DL; Arnold DL
    Neuroimage; 2020 Jul; 214():116737. PubMed ID: 32171923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliable measurements of brain atrophy in individual patients with multiple sclerosis.
    Smeets D; Ribbens A; Sima DM; Cambron M; Horakova D; Jain S; Maertens A; Van Vlierberghe E; Terzopoulos V; Van Binst AM; Vaneckova M; Krasensky J; Uher T; Seidl Z; De Keyser J; Nagels G; De Mey J; Havrdova E; Van Hecke W
    Brain Behav; 2016 Sep; 6(9):e00518. PubMed ID: 27688944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
    Uher T; Krasensky J; Vaneckova M; Sobisek L; Seidl Z; Havrdova E; Bergsland N; Dwyer MG; Horakova D; Zivadinov R
    J Neuroimaging; 2017 Nov; 27(6):620-629. PubMed ID: 28464417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of brain atrophy measurements in multiple sclerosis using MRI: an assessment of six freely available software packages for cross-sectional analyses.
    van Nederpelt DR; Amiri H; Brouwer I; Noteboom S; Mokkink LB; Barkhof F; Vrenken H; Kuijer JPA
    Neuroradiology; 2023 Oct; 65(10):1459-1472. PubMed ID: 37526657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI.
    Battaglini M; Jenkinson M; De Stefano N;
    Hum Brain Mapp; 2018 Mar; 39(3):1063-1077. PubMed ID: 29222814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.
    Andorra M; Nakamura K; Lampert EJ; Pulido-Valdeolivas I; Zubizarreta I; Llufriu S; Martinez-Heras E; Sola-Valls N; Sepulveda M; Tercero-Uribe A; Blanco Y; Saiz A; Villoslada P; Martinez-Lapiscina EH
    JAMA Neurol; 2018 Oct; 75(10):1246-1255. PubMed ID: 29971335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.